Update on the Phase 4 Confirmatory Study of ADUHELM®

Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 228.48 +0.88 (0.39%)
Previous Close $227.60    52 Week High $333.65 
Open $225.87    52 Week Low $223.02 
Day High $228.58    P/E 29.25 
Day Low $225.51    EPS $7.81 
Volume 50,178